InsiderClue
← All stocks

Viridian Therapeutics, Inc.\DE

VRDN Net buying
CIK 0001590750 #1814 in the set updated 17 Sep 2026
Bought (120 mo)
$98.45M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$11.03M
$0.00 on a plan · $5.19M straight out of an exercise
Sold at will
$5.85M
23 of 42 sales
Net
+$87.42M
+$92.60M against sales at will

By person

23 insiders · 71 transactions
1.1×

Stephen Mahoney holds only 1.1 times base salary in stock. $811.69K of shares against $700.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Stephen Mahoney last reported holding, valued at $24.50, the price Common Stock was last bought or sold at on the open market here, on 19 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Fairmount Funds Management LLC entity
Director
$90.00M (6)
—
+$90.00M
5,617,321
4.96%
$137.62M
+15,907%
Violin Jonathan
Chief Executive Officer
—
$4.27M (10)
−$4.27M
430,905
0.3803%
$10.56M
—
Katz Barrett
Chief Medical Officer
—
$3.17M (4) scheduled
−$3.17M
0
0.0000%
$0.00
—
Booth Bruce
Director
$3.00M (1)
—
+$3.00M
3,142,580
2.77%
$76.99M
+21.0%
Meisner Lara
Chief Legal Officer
—
$2.54M (14) scheduled
−$2.54M
29,971
0.0265%
$734.29K
−50.0%
Logos Global Master Fund LP entity
10% owner
$2.27M (3)
—
+$2.27M
550,000
0.4855%
$13.48M
+650.0%
Frazier Life Sciences Public Fund, L.P. entity
10% owner
$2.20M (1)
—
+$2.20M
1,505,200
1.33%
$36.88M
+15.3%
LEFKOFF KYLE
Director
—
$540.14K (10)
−$540.14K
463,473
0.4091%
$11.36M
−7.4%
Mahoney Stephen F.
President and CEO
$499.26K (1)
—
+$499.26K
33,130
0.0292%
$811.69K
+3,213%
Tousignant Jennifer
Chief Legal Officer
—
$418.99K (3) scheduled
−$418.99K
0
0.0000%
$0.00
−100.0%
Myers Scott Dunseth
Chief Executive Officer
$261.80K (2)
—
+$261.80K
259,500
0.2291%
$6.36M
—
Beetham Thomas W.
Chief Operating Officer
$117.05K (1)
—
+$117.05K
13,271
0.0117%
$325.14K
+563.6%
Levy Adam Scott
Chief Business Officer
$51.51K (2)
—
+$51.51K
13,040
0.0115%
$319.48K
+247.7%
Hughes Thomas E.
Director
$47.70K (1)
$96.00K (1)
−$48.30K
12,827
0.0113%
$314.26K
−8.7%
Riccitelli Samuel D
President & CEO
—
—
—
571,370
0.5043%
$14.00M
+20.4%
LEBOW BENNETT S
Director
—
—
—
429,441
0.3791%
$10.52M
+187.9%
Marshall William Stuart
See Remarks
—
—
—
273,146
0.2411%
$6.69M
+73.6%
FAVORITO TAMARA A
CFO, Secretary, Treasurer
—
—
—
106,447
0.0940%
$2.61M
+294.3%
Leverone Jason A.
Chief Financial Officer
—
—
—
48,829
0.0431%
$1.20M
+885.1%
Tripuraneni Radhika
Chief Medical Officer
—
—
—
40,000
0.0353%
$980.00K
—
Harmon Seth
Chief Financial Officer
—
—
—
7,790
0.0069%
$190.86K
+115.6%
Smith Robin L
Director
—
—
—
1,900
0.0017%
$46.55K
+171.4%
Gonyer David A
Director
—
—
—
1,899
0.0017%
$46.53K
+171.7%

Individual transactions

71
Insider
Date
Role
Action
Shares
Price
Amount
Tousignant Jennifer
19 Aug 2026
Chief Legal Officer
Sold after exercise
10,000
$24.50
$245.00K
Tousignant Jennifer
19 Aug 2026
Chief Legal Officer
Sold after exercise
4,212
$24.50
$103.19K
Tripuraneni Radhika
14 Aug 2026
Chief Medical Officer
Exercised, kept
40,000
$13.21
$528.40K
Fairmount Funds Management LLC
11 May 2026
Director
Buy indirect
1,176,470
$17.00
$20.00M
Tousignant Jennifer
31 Dec 2025
Chief Legal Officer
Sell
2,272
$31.16
$70.80K
Fairmount Funds Management LLC
23 Oct 2025
Director
Buy indirect
454,545
$22.00
$10.00M
Fairmount Funds Management LLC
10 Jun 2025
Director
Exercised, kept indirect
12,500
$12.31
$153.88K
Fairmount Funds Management LLC
9 Jun 2025
Director
Exercised, kept indirect
1,600
$7.80
$12.48K
Mahoney Stephen F.
27 Sep 2024
President and CEO
Buy
21,400
$23.33
$499.26K
Beetham Thomas W.
27 Sep 2024
Chief Operating Officer
Buy
5,000
$23.41
$117.05K
Fairmount Funds Management LLC
13 Sep 2024
Director
Buy indirect
1,600,000
$18.75
$30.00M
Fairmount Funds Management LLC
22 Jan 2024
Director
Buy indirect
476,190
$21.00
$10.00M
Meisner Lara
16 Jun 2023
Chief Legal Officer
Sold after exercise
27
$28.35
$765.45
Meisner Lara
15 Jun 2023
Chief Legal Officer
Sold after exercise
2,269
$28.02
$63.58K
Meisner Lara
6 Jun 2023
Chief Legal Officer
Sold after exercise
5,126
$25.02
$128.25K
Meisner Lara
5 Jun 2023
Chief Legal Officer
Sold after exercise
499
$25.03
$12.49K
Meisner Lara
2 Jun 2023
Chief Legal Officer
Sold after exercise
1,875
$24.21
$45.39K
Myers Scott Dunseth
12 Apr 2023
Chief Executive Officer
Buy
4,000
$25.37
$101.48K
Myers Scott Dunseth
13 Mar 2023
Chief Executive Officer
Buy
5,500
$29.15
$160.32K
Meisner Lara
9 Mar 2023
General Counsel and Secretary
Sell
29,971
$29.07
$871.26K
Violin Jonathan
2 Feb 2023
Chief Executive Officer
Sell
50,000
$36.80
$1.84M
Meisner Lara
23 Jan 2023
General Counsel and Secretary
Sold after exercise
6,843
$35.66
$244.02K
Katz Barrett
17 Jan 2023
Chief Medical Officer
Sold after exercise
24,853
$37.21
$924.78K
Katz Barrett
13 Jan 2023
Chief Medical Officer
Sold after exercise
4,147
$37.01
$153.48K
Katz Barrett
10 Jan 2023
Chief Medical Officer
Sold after exercise
47,377
$35.30
$1.67M
Katz Barrett
9 Jan 2023
Chief Medical Officer
Sold after exercise
12,623
$33.04
$417.06K
Meisner Lara
21 Dec 2022
General Counsel and Secretary
Sold after exercise
16,326
$29.19
$476.56K
Meisner Lara
20 Dec 2022
General Counsel and Secretary
Sold after exercise
600
$28.07
$16.84K
Meisner Lara
16 Dec 2022
General Counsel and Secretary
Sold after exercise
1,297
$28.44
$36.89K
Meisner Lara
15 Dec 2022
General Counsel and Secretary
Sold after exercise
300
$28.08
$8.42K
Meisner Lara
14 Dec 2022
General Counsel and Secretary
Sold after exercise
15,656
$28.12
$440.25K
Meisner Lara
12 Dec 2022
General Counsel and Secretary
Sold after exercise
600
$28.05
$16.83K
Meisner Lara
15 Nov 2022
General Counsel and Secretary
Sold after exercise
8,125
$22.05
$179.16K
Fairmount Funds Management LLC
17 Aug 2022
Director
Buy indirect
425,531
$23.50
$10.00M
Violin Jonathan
1 Jun 2022
Chief Executive Officer
Sell
30,000
$12.20
$366.00K
Violin Jonathan
2 May 2022
Chief Executive Officer
Sell
30,000
$13.04
$391.20K
Violin Jonathan
4 Apr 2022
Chief Executive Officer
Sell
3,600
$18.93
$68.15K
Violin Jonathan
1 Apr 2022
Chief Executive Officer
Sell
26,400
$18.92
$499.49K
Violin Jonathan
2 Mar 2022
Chief Executive Officer
Sell
11,106
$17.36
$192.80K
Violin Jonathan
1 Mar 2022
Chief Executive Officer
Sell
18,894
$17.82
$336.69K
Violin Jonathan
3 Feb 2022
Chief Executive Officer
Sell
909
$19.16
$17.42K
Violin Jonathan
2 Feb 2022
Chief Executive Officer
Sell
12,340
$18.47
$227.92K
Violin Jonathan
1 Feb 2022
Chief Executive Officer
Sell
16,751
$19.55
$327.48K
Frazier Life Sciences Public Fund, L.P.
23 Sep 2021
10% owner
Buy
200,000
$11.00
$2.20M
Fairmount Funds Management LLC
21 Sep 2021
Director
Buy indirect
909,000
$11.00
$10.00M
Logos Global Master Fund LP
13 Nov 2020
10% owner
Buy
126,667
$14.84
$1.88M
Logos Global Master Fund LP
9 Nov 2020
10% owner
Buy
100,000
$1.16
$116.41K
Logos Global Master Fund LP
9 Nov 2020
10% owner
Buy
250,000
$1.10
$274.48K
Leverone Jason A.
13 Mar 2020
CFO, Treasurer & Secretary
Exercised, kept
11,249
$0.57
$6.41K
Leverone Jason A.
23 Aug 2019
CFO, Treasurer & Secretary
Exercised, kept
3,093
$0.57
$1.76K
Hughes Thomas E.
11 Oct 2018
Director
Buy
10,000
$4.77
$47.70K
Leverone Jason A.
7 Aug 2018
CFO, Treasurer & Secretary
Exercised, kept
29,530
$0.57
$16.83K
Booth Bruce
13 Feb 2018
Director
Buy indirect
545,454
$5.50
$3.00M
Levy Adam Scott
13 Feb 2018
Chief Business Officer
Buy
9,090
$5.50
$50.00K
Marshall William Stuart
13 Feb 2018
President & CEO
Exercised, kept
115,818
$0.57
$66.02K
Hughes Thomas E.
20 Dec 2017
Director
Sell
12,000
$8.00
$96.00K
Levy Adam Scott
22 Jun 2017
Chief Business Officer
Buy
200
$7.55
$1.51K
LEFKOFF KYLE
10 Mar 2017
Director
Sell indirect
3,300
$14.31
$47.23K
LEFKOFF KYLE
9 Mar 2017
Director
Sell indirect
2,500
$14.38
$35.96K
LEFKOFF KYLE
8 Mar 2017
Director
Sell indirect
5,000
$14.70
$73.51K
LEFKOFF KYLE
6 Mar 2017
Director
Sell indirect
608
$16.24
$9.87K
LEFKOFF KYLE
6 Mar 2017
Director
Sell indirect
9,392
$15.71
$147.59K
LEFKOFF KYLE
28 Feb 2017
Director
Sell indirect
2,258
$13.54
$30.58K
LEFKOFF KYLE
27 Feb 2017
Director
Sell indirect
1,500
$13.79
$20.69K
LEFKOFF KYLE
24 Feb 2017
Director
Sell indirect
6,500
$14.04
$91.25K
LEFKOFF KYLE
23 Feb 2017
Director
Sell indirect
1,800
$13.65
$24.57K
LEFKOFF KYLE
22 Feb 2017
Director
Sell indirect
4,102
$14.36
$58.89K
LEBOW BENNETT S
13 Feb 2017
Director
Exercised, kept
279,067
$5.39
$1.50M
Gonyer David A
8 Feb 2017
Director
Exercised, kept
1,200
$7.65
$9.18K
Smith Robin L
3 Feb 2017
Director
Exercised, kept
1,200
$7.65
$9.18K
LEBOW BENNETT S
3 Feb 2017
Director
Exercised, kept
1,200
$7.65
$9.18K

What was left out

Form 4 filings counted 182
Amendments (4/A) skipped 8
Filings about a different issuer 0
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 19
Sales at will 23
Transactions with no price 0
Shares from compensation/vesting 2,691,066
Sales filed before the plan box existed 22
History held since 2 Nov 2016